ATE297410T1 - Lupus antikoagulant-antikörper gegen die f1 region von prothrombin - Google Patents

Lupus antikoagulant-antikörper gegen die f1 region von prothrombin

Info

Publication number
ATE297410T1
ATE297410T1 AT99930930T AT99930930T ATE297410T1 AT E297410 T1 ATE297410 T1 AT E297410T1 AT 99930930 T AT99930930 T AT 99930930T AT 99930930 T AT99930930 T AT 99930930T AT E297410 T1 ATE297410 T1 AT E297410T1
Authority
AT
Austria
Prior art keywords
prothrombin
region
antibodies against
lupus anticoagulant
anticoagulant antibodies
Prior art date
Application number
AT99930930T
Other languages
English (en)
Inventor
Thomas Exner
Michael Kraus
Original Assignee
Gradipore Ltd
Dade Behring Marburg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gradipore Ltd, Dade Behring Marburg Gmbh filed Critical Gradipore Ltd
Application granted granted Critical
Publication of ATE297410T1 publication Critical patent/ATE297410T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99930930T 1998-07-10 1999-07-09 Lupus antikoagulant-antikörper gegen die f1 region von prothrombin ATE297410T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP4603A AUPP460398A0 (en) 1998-07-10 1998-07-10 Lupus anticoagulant
PCT/AU1999/000556 WO2000002925A1 (en) 1998-07-10 1999-07-09 Lupus anticoagulant antibody to f1 region of prothrombin

Publications (1)

Publication Number Publication Date
ATE297410T1 true ATE297410T1 (de) 2005-06-15

Family

ID=3808841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99930930T ATE297410T1 (de) 1998-07-10 1999-07-09 Lupus antikoagulant-antikörper gegen die f1 region von prothrombin

Country Status (8)

Country Link
EP (1) EP1097174B1 (de)
JP (1) JP2002520012A (de)
AT (1) ATE297410T1 (de)
AU (1) AUPP460398A0 (de)
CA (1) CA2334078A1 (de)
DE (1) DE69925736T2 (de)
ES (1) ES2241292T3 (de)
WO (1) WO2000002925A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244574B2 (en) 2001-03-19 2007-07-17 Eisai Co., Ltd Method of assaying lupus anticoagulant and assay reagent
ES2857551T3 (es) 2017-06-08 2021-09-29 Siemens Healthcare Diagnostics Products Gmbh Calibración de anticoagulante lúpico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903930A1 (en) * 1989-11-06 1991-05-08 Akzo Nv Immunoassays for and monoclonal antibodies to prothrombin¹activation peptides and their degradation products
WO1991017177A1 (en) * 1990-05-04 1991-11-14 Baxter Diagnostics Inc. High affinity antibodies to small peptides

Also Published As

Publication number Publication date
WO2000002925A1 (en) 2000-01-20
JP2002520012A (ja) 2002-07-09
EP1097174A4 (de) 2002-08-14
AUPP460398A0 (en) 1998-08-06
DE69925736D1 (de) 2005-07-14
EP1097174B1 (de) 2005-06-08
DE69925736T2 (de) 2006-03-16
ES2241292T3 (es) 2005-10-16
EP1097174A1 (de) 2001-05-09
CA2334078A1 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
ATE303101T1 (de) Vorrichtungen zur reparatur von arterien
DK1088084T3 (da) Erythropoietin analog-humant serumalbumin fusionsprotein
TR199801390T2 (xx) Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
ATE264863T1 (de) 28-epirapaloge
BR0215397A (pt) Pensos cirúrgicos revestidos
DE3789371D1 (de) Aryloxy- und Arylacyloxymethyl-Ketone als Thiolprotease-Hemmungsstoffe.
ATE339196T1 (de) Zelladhäsionsinhibitoren
DK0650512T3 (da) Aldehyd-hærdet klæbemiddel på grundlag af protein
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
HN1996000017A (es) Isotiazolonas
ATE234092T1 (de) 2-alkylpyrrolidine
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
DE69523722D1 (de) Bioaktive poröse trennteile
EE03619B1 (et) Süsivesik-modifitseeritud tsütostaatikumid
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
TR200001313T2 (tr) Protein etkileşimlerini ve fonksiyonel ilişkileri kaydeden tarama sistemleri
BR9703386A (pt) Células aviárias imortalizadas
ES2181168T3 (es) Mezclas solidas a base de sulfonilureas y adyuvantes.
DE60022623D1 (de) Thrombozyten-aktivierten vollblutgerinnungszeit
DE68915112D1 (de) Spiro-isochinolin-pyrrolidin-tetrone und Analoge davon, verwendbar als Aldosereduktase-Inhibitoren.
BR0314139A (pt) Derivados de 1,4-pirazina substituìdos
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
DE69925736D1 (de) Lupus antikoagulant-antikörper gegen die f1 region von prothrombin
ES2120506T3 (es) Nuevas amidas, sulfonamidas y sulfonamidas de piperidilo utilizadas como inhibidores de la biosintesis del colesterol.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties